Suppliers / Jiangsu Tasly Diyi Pharmaceutical

Jiangsu Tasly Diyi Pharmaceutical

China 43 employees Updated 9 July 2026

Jiangsu Tasly Diyi Pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules. Its filings concentrate with NMPA (CN), DAV (Vietnam) and NPRA (MY). Its GMP standing is certified by MFDS (Korea).

2
active US DMFs
0
valid CEPs
1
registered plants
22
filings across 3 regulators

Registered plants

Site FDA FEI
Huai'an City, China Not on file

What they file, and where

Molecule Regulators Docs
Pimavanserin US FDA 1
Temozolomide US FDA 1

Also appears on these molecule pages

Pimavanserin API Temozolomide API

Filings and GMP by regulator

Regulator Filings GMP certificates
NMPA (CN) 16 None
DAV (Vietnam) 4 None
NPRA (MY) 2 None
MFDS (Korea) None 2

Questions about Jiangsu Tasly Diyi Pharmaceutical

Does Jiangsu Tasly Diyi Pharmaceutical hold a US DMF or a CEP?
Jiangsu Tasly Diyi Pharmaceutical holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Jiangsu Tasly Diyi Pharmaceutical manufacture?
1 registered site is on record, in China (Huai'an City). Every site is listed on this page with the register it came from.
What does Jiangsu Tasly Diyi Pharmaceutical make?
2 molecules are on record against Jiangsu Tasly Diyi Pharmaceutical, including Pimavanserin and Temozolomide. Each links through to that molecule's full manufacturer list.
Which regulators recognise Jiangsu Tasly Diyi Pharmaceutical's GMP?
Current GMP certificates are on record from MFDS (Korea). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Jiangsu Tasly Diyi Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Hetero shares 1 molecule Cipla shares 1 molecule Zydus Lifesciences shares 1 molecule Biophore India Pharmaceuticals shares 1 molecule Laurus Labs shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates